The company has devoted a certain amount of revenue each year to continuing the fight against cancer by developing new detection tools.

“Nuclepore – another ’64 polymer advance – is now in production at Pleasanton, Calif., supplying medical and other customers with a filter whose extremely fine pores can be used in such ways as isolating cancer cells for medical research.”

GE Annual Report, 1965

 

For almost half a century GE has been on the front lines of cancer research. The company’s scientists and researchers have been central to the development and improvement of cancer screening tools that have detected cancer before it kills.

READ THIS ARTICLE FOR $15
$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in